{
  "ptid_time": "099_S_2063_2010-10-15",
  "img_path": "/data/qiuhui/data/adni/images/099_S_2063/2010-10-15/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 38,594 mm³, 28.5% above the reference mean. With a Z-score of 0.68 (75.1th percentile), this represents normal volume ; whole brain volume measures 1,194,260 mm³, 5.3% above the reference mean. With a Z-score of 0.75 (77.2th percentile), this represents normal volume ; entorhinal cortex volume measures 4,185 mm³, 1.8% below the reference mean. With a Z-score of -0.13 (45.0th percentile), this represents normal volume ; fusiform gyrus volume measures 19,984 mm³, 0.4% above the reference mean. With a Z-score of 0.03 (51.3th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,562 mm³, 0.7% above the reference mean. With a Z-score of 0.06 (52.2th percentile), this represents normal volume . ",
  "text_data": "Age is 68.3 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Cardiovascular; Endocrine-Metabolic; Malignancy; Major Surgical Procedures. MMSE: 30.0. MoCA: 20.0. Logical Memory: 9.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.31 SUVR (moderate elevated); Amyloid beta: 564.40 pg/mL (mild reduced); Total tau: 287.80 pg/mL (normal ); Phosphorylated tau: 29.10 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The brain volumes (ventricular, whole brain, entorhinal cortex, fusiform gyrus, and middle temporal gyrus) are all within normal ranges, with no significant atrophy. However, the MoCA score of 20 suggests cognitive impairment, while the MMSE of 30 is normal, indicating a possible discrepancy. The presence of APOE4 and moderately elevated AV45 (amyloid PET) with mildly reduced Aβ (CSF) suggests amyloid pathology, but normal tau levels argue against advanced neurodegeneration.  \n\n**Diagnosis:** **MCI (Mild Cognitive Impairment)**  \n**Confidence:** **Medium** (due to conflicting cognitive scores and biomarker findings—normal tau but amyloid positivity suggests early-stage cognitive decline rather than full dementia).",
  "timestamp": "2025-07-26T11:01:55.682304"
}